Suraksha Diagnostic

SURAKSHA

Q: How strong is Suraksha Diagnostic balance sheet?

Balance sheet of Suraksha Diagnostic is strong.It shouldn't have solvency or liquidity issues.

Q: Is the debt of Suraksha Diagnostic increasing or decreasing?

Yes, The net debt of Suraksha Diagnostic is increasing.Latest net debt of Suraksha Diagnostic is -₹14.28 Crs as of Mar-25.This is greater than Mar-24 when it was -₹100.8 Crs.

Q: Is Suraksha Diagnostic stock expensive?

Suraksha Diagnostic is not expensive.Latest PE of Suraksha Diagnostic is 54.58, while 3 year average PE is 70.24. Also latest EV/EBITDA of Suraksha Diagnostic is 21.5 while 3yr average is 22.03.

Price

Small Cap

₹1,737 Cr.

New to Zerodha? Sign-up for free.

Suraksha Diagnostic provides comprehensive pathology and radiology testing services along with medical consultations, X-rays, ultrasonography, CT scans, MRI scans, and vaccination services. They also offer omnichannel medical consultations through online and offline platforms.

Suraksha Diagnostic provides comprehensive pathology and radiology testing services along with medi… More

Low

231

52W Range

High

449

54.58

Sector PE

37.83

P/B

8.22

Div.Yield

ROE

13.17%

EBIDTA

21.5

ROCE

16.04

EPS

1.42

New to Zerodha? Sign-up for free.

Share Price
Financials
Revenue mix
Shareholdings
Peers
Forensics

This data is currently unavailable for this company.

Summary
Profit & Loss
Balance sheet
Cashflow

View Detailed Summary

This data is currently unavailable for this company.

Yearly | Quarterly

(In Cr.)

(In Cr.)
This data is currently unavailable for this company.

Financial Ratio's

(In %)

Detailed P&L Report

(In Cr.)

Detailed Balance Sheet

Financial Year (In Cr.)

Detailed Cash Flow

Product wise
Location wise

SURAKSHA
Revenue Mix

Latest

Historic

This data is currently unavailable for this company.

SURAKSHA
Revenue Mix

Latest

Historic

This data is currently unavailable for this company.

More Info

Shareholdings

Holders

Detailed Shareholdings

This data is currently unavailable for this company.

Peers

Detailed Peers

Forensics

View Detailed Forensics

Recent events

News
Corporate Actions

Suraksha Diagnostic Completes Acquisition In Fetomat Wellness

Apr 09, 2025

Suraksha Diagnostic Approves Strategic Investment Of 51.9 Million Rupees In Fetomat

Mar 27, 2025

Suraksha Diagnostic Incorporates Subsidiary Suraksha Advanced Radiology

Jan 22, 2025

Suraksha Diagnostic Approves Formation Of Spv With Suraksha Diagnostic & Eye Centre

Dec 20, 2024

Events:

Quarterly Results

Announcement Date

May 28, 2025

Quarterly Results

Announcement Date

Feb 08, 2025

Quarterly Results

Announcement Date

Dec 20, 2024

More Small Cap Ideas

See similar 'Small' cap companies with recent activity

Promoter Buying

Companies where the promoters are bullish

Detailed List

Capex

Companies investing on expansion

Detailed List

Superstar Investor

Companies where well known investors have invested

Detailed List

Popular questions

Business
Financials
Share Price
Shareholdings

What does Suraksha Diagnostic do?

Suraksha Diagnostic offers one-stop integrated solutions for pathology and radiology testing and medical consultation services including X-rays, ultrasonography, computerized tomography, magnetic resonance imaging scans and vaccination services. In addition to integrated pathology and radiology testing services, it also offers omnichannel medical consultation services via online and offline modes to its customers.

Who are the competitors of Suraksha Diagnostic?

Suraksha Diagnostic major competitors are Dr. Lal Pathlabs, Metropolis Health., Thyrocare Tech., Vijaya Diagnostic. Market Cap of Suraksha Diagnostic is ₹1,737 Crs. While the median market cap of its peers are ₹9,279 Crs.

Is Suraksha Diagnostic financially stable compared to its competitors?

Suraksha Diagnostic seems to be less financially stable compared to its competitors. Altman Z score of Suraksha Diagnostic is 10.64 and is ranked 4 out of its 5 competitors.

Does Suraksha Diagnostic pay decent dividends?

The company seems to be paying a very low dividend. Investors need to see where the company is allocating its profits. Suraksha Diagnostic latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

How has Suraksha Diagnostic allocated its funds?

Companies resources are allocated to majorly productive assets like Plant & Machinery

How strong is Suraksha Diagnostic balance sheet?

Balance sheet of Suraksha Diagnostic is strong. It shouldn't have solvency or liquidity issues.

Is the profitablity of Suraksha Diagnostic improving?

Yes, profit is increasing. The profit of Suraksha Diagnostic is ₹29.63 Crs for TTM, ₹23.63 Crs for Mar 2024 and ₹6.52 Crs for Mar 2023.

Is the debt of Suraksha Diagnostic increasing or decreasing?

Yes, The net debt of Suraksha Diagnostic is increasing. Latest net debt of Suraksha Diagnostic is -₹14.28 Crs as of Mar-25. This is greater than Mar-24 when it was -₹100.8 Crs.

Is Suraksha Diagnostic stock expensive?

Suraksha Diagnostic is not expensive. Latest PE of Suraksha Diagnostic is 54.58, while 3 year average PE is 70.24. Also latest EV/EBITDA of Suraksha Diagnostic is 21.5 while 3yr average is 22.03.

Has the share price of Suraksha Diagnostic grown faster than its competition?

There is not enough historical data for the companies share price.

Is the promoter bullish about Suraksha Diagnostic?

Promoters stake in the company seems stable, and we need to go through filings and allocation of resources to gauge promoter bullishness. Latest quarter promoter holding in Suraksha Diagnostic is 48.78% and last quarter promoter holding is 48.78%.

Are mutual funds buying/selling Suraksha Diagnostic?

The mutual fund holding of Suraksha Diagnostic is increasing. The current mutual fund holding in Suraksha Diagnostic is 19.26% while previous quarter holding is 17.64%.

SURAKSHA

Share Price

Financials

Revenue mix

Shareholdings

Peers

Forensics

Summary

Profit & Loss

Balance sheet

Cashflow

Product wise

Location wise

Recent events

News

Corporate Actions

Suraksha Diagnostic Completes Acquisition In Fetomat Wellness

Suraksha Diagnostic Approves Strategic Investment Of 51.9 Million Rupees In Fetomat

Suraksha Diagnostic Incorporates Subsidiary Suraksha Advanced Radiology

Suraksha Diagnostic Approves Formation Of Spv With Suraksha Diagnostic & Eye Centre

Events:

Quarterly Results

Quarterly Results

Quarterly Results

More Small Cap Ideas

Promoter Buying

Capex

Superstar Investor

Popular questions

Business

Financials

Share Price

Shareholdings

What does Suraksha Diagnostic do?

Who are the competitors of Suraksha Diagnostic?

Is Suraksha Diagnostic financially stable compared to its competitors?

Does Suraksha Diagnostic pay decent dividends?

How has Suraksha Diagnostic allocated its funds?

How strong is Suraksha Diagnostic balance sheet?

Is the profitablity of Suraksha Diagnostic improving?

Is the debt of Suraksha Diagnostic increasing or decreasing?

Is Suraksha Diagnostic stock expensive?

Has the share price of Suraksha Diagnostic grown faster than its competition?

Is the promoter bullish about Suraksha Diagnostic?

Are mutual funds buying/selling Suraksha Diagnostic?